This site uses cookies. For more information, please see ourPrivacy Policy
中裕新藥
  • About
    • About TaiMed
    • Leadership
    • Board
  • Our Science
  • Pipeline & Products
    • Pipeline Overview
    • TMB-365/TMB-380
    • TMB-365
    • Trogarzo®
    • CD4-ADC Platform
  • CDMO
    • CDMO Services
  • Partners
  • News
  • Investors
  • Company Introduction
    • Investors
  • Financials
    • Monthly Revenue
    • Financial Reports
  • Corparate Govemance
    • Organization
    • Board
    • Committee
    • Internal Audit
    • Major Internal Policies
  • Shareholders' Services
    • Major Shareholders
    • Dividend Information
    • Shareholder's Meeting
  • Investor Presentations
    • Institutional Investor Conference Information
  • Sustainable Development
    • ESG
MENU
( En )
  • En
  • 繁中
search
Contact CDMO Service
CLOSE
En 繁中
  • About
    • About TaiMed
    • Leadership
    • Board
  • Our Science
  • Pipeline & Products
    • Pipeline Overview
    • TMB-365/TMB-380
    • TMB-365
    • Trogarzo®
    • CD4-ADC Platform
  • CDMO
    • CDMO Services
  • Partners
  • News
  • Investors
    • Company Introduction
      • Investors
    • Financials
      • Monthly Revenue
      • Financial Reports
    • Corparate Govemance
      • Organization
      • Board
      • Committee
      • Internal Audit
      • Major Internal Policies
    • Shareholders' Services
      • Major Shareholders
      • Dividend Information
      • Shareholder's Meeting
    • Investor Presentations
      • Institutional Investor Conference Information
    • Sustainable Development
      • ESG

Financial report

  • Home
  • Financial report
GO
  • Number
    File name
    Date
    Q1
    Q2
    Q3
    Consolidated Report
    Individual Report
    Annual Report
  • 01
    2026 Quarterly Financial Report
    2026-08-31
    Q1 Q2
  • 02
    2025 Quarterly Financial Report
    2025-06-09
    Q1 Q2 Q3 Consolidated Report Individual Report Annual Report
  • 03
    2024 Quarterly Financial Report
    2024-06-12
    Q1 Q2 Q3 Consolidated Report Individual Report Annual Report
  • 04
    2023 Quarterly Financial Report
    2023-07-17
    Q1 Q2 Q3 Consolidated Report Individual Report Annual Report
  • 05
    2022 Quarterly Financial Report
    2023-07-17
    Q1 Q2 Q3 Consolidated Report Individual Report Annual Report
  • 06
    2021 Quarterly Financial Report
    2023-07-17
    Q1 Q2 Q3 Consolidated Report Individual Report Annual Report
  • 07
    2020 Quarterly Financial Report
    2023-07-17
    Q1 Q2 Q3 Consolidated Report Individual Report Annual Report
  • 08
    2019 Quarterly Financial Report
    2023-07-17
    Q1 Q2 Q3 Consolidated Report Individual Report Annual Report
  • 09
    2018 Quarterly Financial Report
    2023-07-17
    Q1 Q2 Q3 Consolidated Report Individual Report Annual Report
  • 10
    2017 Quarterly Financial Report
    2023-07-17
    Q1 Q2 Q3 Consolidated Report Individual Report Annual Report
  • 11
    2016 Quarterly Financial Report
    2023-07-17
    Q1 Q2 Q3 Consolidated Report Individual Report Annual Report
  • 12
    2015 Quarterly Financial Report
    2023-07-17
    Q1 Q2 Q3 Consolidated Report Individual Report Annual Report
  • Return to previous page
TaiMed Biologics is a commercial-stage CD4-targeted biologics company advancing antibody-based therapies for long-acting HIV treatment and broader immune-directed innovation.
About  |  Our Science  |  Pipeline & Products  |  CDMO  |  Partners  |  News  |  Investors
 
TaiMed HQ
  • TEL:02-26580058
  • TIME:8:00AM-18:00PM
  • E-mail:ir@taimedbio.com
  • ADD:3F.,NO.607,Ruiguang Rd.,Neihu Dist.,Taipei City 11492,Taiwan(R.O.C.)
Hsinchu Branch Office
  • TEL:03-6212355
  • TIME:8:00AM-18:00PM
  • ADD:No. 18, Ln. 15, Shengyi 5th Rd., Zhubei City, Hsinchu County, Taiwan (R.O.C.)
  • Contact CDMO Service
中裕新藥股份有限公司
Corporate General InquiriesPrivacyBusiness Development PartnershipsInvestor RelationsCDMO Services
TaiMed / Taimedbiologics / Clinical Development of Anti-HIV Medications / Trogarzo® / TaiMed biologics cdmo / cdmo services / HIV / cGMP Facility
256 bit SSL Encryption
Recommend using Chrome, Firefox, Safari latest version of the browser.
Designed by MIRACLEWeb Design
Contact CDMO Service